Marinus Pharmaceuticals (NASDAQ:MRNS) Raised to Strong-Buy at EF Hutton Acquisition Co. I
EF Hutton Acquisition Co. I upgraded shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) to a strong-buy rating in a research note published on Monday, Zacks.com reports. A number of other research analysts have also weighed in on the company. Truist Financial reissued a buy rating and set a $10.00 price target on shares of […]
More Stories
PennantPark Investment Co. (PNNT) to Issue Monthly Dividend of $0.08 on November 1st
PennantPark Investment Co. (NASDAQ:PNNT – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, Wall Street Journal reports....
Global X SuperDividend REIT ETF (NASDAQ:SRET) to Issue Monthly Dividend of $0.16
Global X SuperDividend REIT ETF (NASDAQ:SRET – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, NASDAQ reports....
Cohen & Steers Select Preferred and Income Fund, Inc. (PSF) to Issue Monthly Dividend of $0.13 on November 29th
Cohen & Steers Select Preferred and Income Fund, Inc. (NYSE:PSF – Get Free Report) announced a monthly dividend on Wednesday,...
Gear Energy Ltd. Plans Monthly Dividend of $0.01 (TSE:GXE)
Gear Energy Ltd. (TSE:GXE – Get Free Report) announced a monthly dividend on Wednesday, October 2nd, Zacks reports. Investors of...
Cohen & Steers Infrastructure Fund, Inc (UTF) To Go Ex-Dividend on November 12th
Cohen & Steers Infrastructure Fund, Inc (NYSE:UTF – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, Wall...
NovaGold Resources (NYSEAMERICAN:NG) Announces Quarterly Earnings Results
NovaGold Resources (NYSEAMERICAN:NG – Get Free Report) (TSE:NG) issued its quarterly earnings results on Wednesday. The mining company reported ($0.03)...